Literature DB >> 18544636

Association of tetraspanin CD9 with transmembrane TGF{alpha} confers alterations in cell-surface presentation of TGF{alpha} and cytoskeletal organization.

Isabella Imhof1, Warren J Gasper, Rik Derynck.   

Abstract

Ligand presentation is a major determinant of receptor activation. The epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, is activated by growth factors of the transforming growth factor alpha (TGFalpha) family. The tetraspanin CD9 interacts with transmembrane TGFalpha and decreases its ectodomain shedding to release soluble TGFalpha. Here we report that CD9 has a role in the maturation of transmembrane TGFalpha and its stabilization at the cell surface, and in the cell-surface distribution in polarized epithelial cells. Furthermore, coexpression of CD9 and TGFalpha confers changes in cytoskeletal organization with a decrease in actin stress fibers and focal adhesions, and changes in RhoA and Rac1 GTPase activity. These alterations are reversed by blocking EGFR signaling. Finally, we demonstrate changes in cell adhesion and migration resulting from coexpression of TGFalpha with CD9. These results provide insight into the role of CD9 in the presentation of TGFalpha in epithelial and carcinoma cells, whose physiology is driven by ligand-induced EGFR activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544636     DOI: 10.1242/jcs.021717

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  16 in total

1.  Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth.

Authors:  Alexander Stoeck; Li Shang; Peter J Dempsey
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

2.  Immunohistochemical distribution of the tetraspanin CD9 in normal porcine tissues.

Authors:  Noemí Yubero; Angeles Jiménez-Marín; Concepción Lucena; Manuel Barbancho; Juan J Garrido
Journal:  Mol Biol Rep       Date:  2010-06-29       Impact factor: 2.316

Review 3.  Tetraspanins and tumor progression.

Authors:  Mekel M Richardson; Lisa K Jennings; Xin A Zhang
Journal:  Clin Exp Metastasis       Date:  2010-12-24       Impact factor: 5.150

Review 4.  Tetraspanins: push and pull in suppressing and promoting metastasis.

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

5.  Reck enables cerebrovascular development by promoting canonical Wnt signaling.

Authors:  Florian Ulrich; Jorge Carretero-Ortega; Javier Menéndez; Carlos Narvaez; Belinda Sun; Eva Lancaster; Valerie Pershad; Sean Trzaska; Evelyn Véliz; Makoto Kamei; Andrew Prendergast; Kameha R Kidd; Kenna M Shaw; Daniel A Castranova; Van N Pham; Brigid D Lo; Benjamin L Martin; David W Raible; Brant M Weinstein; Jesús Torres-Vázquez
Journal:  Development       Date:  2015-12-10       Impact factor: 6.868

Review 6.  From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

7.  Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation.

Authors:  Pinglong Xu; Rik Derynck
Journal:  Mol Cell       Date:  2010-02-26       Impact factor: 17.970

8.  Functional and biochemical studies of CD9 in fibrosarcoma cell line.

Authors:  Shuli Chen; Yingxia Sun; Zhigao Jin; Xianghong Jing
Journal:  Mol Cell Biochem       Date:  2010-12-14       Impact factor: 3.396

9.  Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals.

Authors:  Ayelet Zlotogorski-Hurvitz; Dan Dayan; Gavriel Chaushu; Tuula Salo; Marilena Vered
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-27       Impact factor: 4.553

10.  IL-15: a novel prosurvival signaling pathway in cardiomyocytes.

Authors:  Yerem Yeghiazarians; Norman Honbo; Isabella Imhof; Brandon Woods; Vanessa Aguilera; Jianqin Ye; Andrew J Boyle; Joel S Karliner
Journal:  J Cardiovasc Pharmacol       Date:  2014-05       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.